Sacred, Banned & Booming: The Complete Story of Cannabis in India
- THC INDIA STORE

- 2 days ago
- 18 min read
India's relationship with cannabis defies simple characterization—it is simultaneously one of the world's largest cannabis-consuming nations and a country with harsh prohibition laws. 31 million Indians (2.83% of the population aged 10-75) currently use cannabis products, with Delhi ranking third globally for consumption at 38.2 tonnes annually.

Yet this consumption occurs within a paradoxical legal framework where the same plant can be sacred prasad offered at Shiva temples or grounds for imprisonment up to 20 years. The NDPS Act of 1985, enacted under American pressure, created an arbitrary distinction that preserved bhang (leaves and seeds) while criminalizing ganja (flowering tops) and charas (resin)—a compromise that simultaneously honored ancient traditions and satisfied international treaty obligations.
As of 2024-2025, India stands at an inflection point: Uttarakhand and Himachal Pradesh are piloting industrial hemp cultivation, medical cannabis through Ayurvedic frameworks has emerged as a rapidly growing industry, and advocacy movements are pushing for decriminalization, even as enforcement agencies report record seizures exceeding ₹16,914 crore worth of narcotics in 2024.
The Complete Story of Cannabis in India
The NDPS Act creates a patchwork of legality
The Narcotic Drugs and Psychotropic Substances Act of 1985 forms the backbone of India's cannabis regulation. Section 2(iii) defines cannabis with a critical exemption—it explicitly excludes seeds and leaves when not accompanied by flowering tops—which forms the legal basis for bhang's continued legality. This distinction means that the same cannabis plant produces both legal and illegal substances depending on which part is used.
Penalties under Section 20 scale dramatically by quantity. For ganja, possessing up to 1 kilogram attracts imprisonment up to one year and a ₹10,000 fine (small quantity), while 20 kilograms or more (commercial quantity) triggers 10-20 years imprisonment plus ₹1-2 lakh fines. For the more potent charas, these thresholds drop to 100 grams and 1 kilogram respectively. Repeat offenses can result in penalties of 1.5 times the original punishment, with serious repeat trafficking potentially attracting 30 years imprisonment.
Section 10 empowers state governments to regulate cultivation, production, and sale of cannabis—excluding charas, which remains under central control. This provision has enabled the divergent state policies that characterize India's cannabis landscape. Section 14 provides special dispensation for cultivation serving industrial purposes (fiber, seeds) or horticulture, forming the legal foundation for the emerging hemp industry.
Bhang enjoys legal status in most states
Multiple High Court rulings have affirmed bhang's exclusion from NDPS prohibition. The Karnataka High Court in 2022 granted bail to a man caught with 29 kilograms of bhang, explicitly stating that "bhang is NOT prohibited under NDPS Act." Similar rulings in Sevaram vs State of Rajasthan (1992), Madhukar vs State of Maharashtra, and Arjun Singh vs State of Haryana have consistently upheld this distinction.
States with legal, regulated bhang sales include Uttar Pradesh (government-licensed shops in Varanasi, Lucknow, Mathura), Rajasthan (widely available in Jaisalmer, Jaipur, Pushkar), Madhya Pradesh, Uttarakhand, Bihar, Odisha, and Punjab. Gujarat created a notable paradox in February 2017 by legalizing bhang in a prohibition state, removing it from the "intoxicating drugs" list under Section 23 of the Gujarat Prohibition Act while maintaining alcohol prohibition.
Several states take stricter positions. Assam explicitly prohibits both ganja and bhang under the Assam Ganja and Bhang Prohibition Act of 1958. Maharashtra requires licenses for bhang under the Bombay Prohibition Act of 1949. Tamil Nadu maintains complete prohibition on sale and use, while Kerala issues no licenses and applies NDPS provisions strictly.
Hemp cultivation pioneers new economic possibilities
Uttarakhand blazed the trail in July 2018 as India's first state to issue commercial hemp cultivation licenses. The state exercised powers under Section 14 of the NDPS Act, establishing a THC limit of ≤0.3% and designating the Centre for Aromatic Plants in Selaqui, Dehradun as the nodal agency. Licensing requires application to the District Magistrate with land ownership documentation, character certificates, and storage facility proof. Critically, sales are restricted to government-authorized buyers only.
The hemp industry, currently valued at USD 2-3 million, is projected to grow to USD 500-700 million. Approximately 100 hemp startups now operate across India, with most sourcing raw material from Uttarakhand. Products span textiles, cosmetics, health foods, construction materials, paper, and bio-plastics. FSSAI's November 2021 notification recognizing hemp seeds as food ingredients—with THC limits of maximum 5 mg/kg—opened the food sector.
Himachal Pradesh represents the most significant recent development. In September 2024, the state assembly passed a resolution to legalize controlled cannabis cultivation for industrial and medicinal purposes. A cabinet-approved pilot study commenced in January 2025, with regions including Kullu, Chamba, and Mandi identified as suitable. The state requires 24-hour CCTV surveillance and geo-tagging of licensed facilities—a response to its paradoxical status as both a major illegal production center (Malana Cream) and an aspiring regulated market.
Uttar Pradesh and Madhya Pradesh have hemp policies at various stages of development, while Manipur announced consideration of legalization in February 2020, potentially leveraging its proximity to the Golden Triangle.
Medical cannabis operates through Ayurvedic frameworks
India's medical cannabis pathway operates through the Ministry of AYUSH rather than conventional pharmaceutical channels. Cannabis—known as Vijaya in Sanskrit—is recognized in the Ayurvedic Pharmacopoeia of India and classified as a Schedule E-1 drug under the Drugs and Cosmetics Act. Over 191 classical formulations mention cannabis as an ingredient across texts including the Charaka Samhita, Sushruta Samhita, and Sharngadhara Samhita.
The January 2022 Central Government affirmation that medical Vijaya use is permitted empowered states to license cultivation for medical purposes. Unlike Western pharmaceutical products, Ayurvedic cannabis formulations derived from traditional texts do not require clinical trials. However, products require manufacture under the Drugs and Cosmetics Act with state AYUSH department approval, and internal-use preparations require prescriptions from registered medical practitioners.
In 2024, the Ministry of AYUSH introduced stricter oversight, requiring state drug authorities to seek central clearance before approving Ayurvedic cannabis drugs. A September 2024 public notice clarified that the Ministry does not endorse "cannabis experts/hempvaidyas/cannabis doctors" as legitimate AYUSH specializations.
Recent court judgments have clarified important procedural points. The Bombay High Court in September 2024 ruled that ganja under NDPS covers only flowering/fruiting tops and excludes seeds, leaves, stems, and stalks—granting bail where seized material lacked flowering tops. Meanwhile, the Kerala High Court clarified that growing any cannabis plant is illegal regardless of flowering status, as cultivation itself is banned under Section 8(b).
Religious traditions weave cannabis into sacred practice
Cannabis holds profound significance in Hindu religious tradition, particularly within Shaivite worship. According to mythology, cannabis originated during the Samudra Manthan (churning of the cosmic ocean)—either as the plant that sprouted from a drop of fallen amrit (nectar of immortality) or as the remedy the Devas prepared to cool Shiva after he consumed the poison Halahala. Shiva is venerated as the "Lord of Bhang" (Bhang ka Devta), depicted in centuries of art smoking ganja from a chillum, his half-closed eyes attributed to either deep meditation or cannabis's effects.
The Atharvaveda (c. 1500-1000 BCE) lists bhanga among five sacred plants that relieve anxiety, describing it as a "source of happiness," "joy-giver," and "liberator." The text notes that a guardian angel was believed to inhabit its leaves. The Sushruta Samhita (c. 600 BCE) recommends bhanga for treating catarrh, phlegm, and diarrhea, establishing its medicinal credentials millennia before Western pharmaceutical recognition.
Festival consumption follows regional patterns
Mahashivratri sees the strongest bhang traditions in Varanasi, where preparations occur on the famous ghats, and in Mathura, where the practice is believed to have been introduced by Shiva's followers. Nepal's Pashupatinath Temple draws approximately 100,000 Hindus, with Nepal lifting its cannabis ban during the festival. Government-licensed bhang shops in Uttar Pradesh and Rajasthan experience peak sales during both Mahashivratri and Holi, when bhang thandai (cannabis-infused milk drink with almonds, pistachios, and spices) becomes nearly ubiquitous across North India.
Beyond drinks, festival preparations include bhang pakoras (fried snacks), bhang ki chutney (particularly in Uttarakhand's hills), bhang goli (freshly ground cannabis balls), bhang gujiya (stuffed sweets), and bhang halwa. The Ambubachi Mela in Assam presents a paradox—thousands consume cannabis despite the state's 1958 prohibition, with police reportedly turning a blind eye to religious consumption.
Sadhu traditions embody cannabis spirituality
Naga Sadhus—warrior-ascetics worshipping Lord Shiva who reside primarily in Himalayan caves—smoke cannabis through the chillum (Shiv Muli) as integral to their sadhana (spiritual practice). Their bodies smeared with ash and hair worn in matted locks like Shiva, they appear publicly primarily during the Kumbh Mela occurring every twelve years. Cannabis serves multiple spiritual functions: avoiding worldly distraction, strengthening meditation, and reducing sexual desire.
The Aghoris, an extreme ascetic sect, consume bhang daily as fundamental religious practice, alongside more transgressive behaviors including smearing bodies with cremation-ground ash and using human skulls as begging bowls. Regular sadhus similarly consume cannabis via chillum smoking or bhang drinks, claiming "Normal people need food, we need ganja." Notably, women sadhvis generally do not partake in chillum smoking.
Sikh Nihangs represent an unusual tradition of bhang consumption during the Hola Mohalla festival, despite Guru Nanak's teachings against mind-altering substances and the Sikh Rehat Maryada's official prohibition. Indian Sufis similarly incorporate bhang into their practice, believing the spirit of Khidr inhabits the cannabis plant.
The Himalayan states navigate between tradition and trafficking
Uttarakhand balances hemp promise with enforcement challenges
Beyond its pioneering hemp policy, Uttarakhand maintains deep traditional cannabis connections. British colonial Gazetteers documented cultivation in Almora and Nainital, where the plant was used for bhangela (traditional clothes), sacks, ropes, and fish nets. Traditional foods including bhang ki chutney and bhang ke pakora remain common in hill communities.
The state's hemp licensing faces a fundamental challenge: maintaining THC below 0.3% proves difficult with indigenous Indian strains, which typically contain 4-5% THC. Many farmers rely on wild cannabis collection under separate "collection licenses" where THC limits don't apply, while commercial cultivation increasingly depends on imported seeds. All thirteen districts are eligible for cultivation, with Chamoli (elevation 800-8,000 meters) and surrounding areas identified as optimal.
Himachal Pradesh confronts its paradoxical reputation
The remote village of Malana (population ~1,700) in the Parvati Valley has achieved global fame for "Malana Cream"—hashish that won High Times Cannabis Cup awards in 1994 and 1996 and commands approximately $250 per tola (11.66 grams) in Amsterdam markets. Produced through traditional hand-rubbing techniques, the charas contains 14-22% THC. The valley's lore holds that Shiva and Parvati themselves brought cannabis seeds here.
An estimated 2,100 hectares are cultivated annually across the Parvati Valley, producing varieties including Tosh Balls, Rashol Cream, and Waichin Charas. Yet this production is entirely illegal, driving intense enforcement: 70 lakh (7 million) cannabis plants destroyed between 2023 and mid-2025, with 5,004 NDPS cases registered in the same period. Seizures included 919 kg charas and 32.9 kg heroin.
The state faces a separate crisis with chitta (heroin-based synthetic drugs), which accounts for 60% of drug addiction cases—spillover from Punjab's trafficking networks. This has prompted an "Anti-Chitta" campaign launched by Chief Minister Sukhvinder Singh Sukhu in December 2024, alongside the new Himachal Pradesh Drugs and Controlled Substances Act introducing stricter penalties.
Rajasthan operates government-authorized bhang infrastructure
Rajasthan permits bhang sale through licensed shops while prohibiting cultivation, requiring imports from production-legal states like Uttar Pradesh. The Rajasthan Excise Department issues retail licenses (₹10,000 wholesale license fee), with sales governed by the Rajasthan Issue and Sale Prices of Bhang Rules of 1964. Famous bhang shops in Jaisalmer have operated since the 1970s with family lineage, serving chocolate, sweets, juices, and buttermilk versions.
Cultural acceptance runs deep, with consumption integrated into Holi and Mahashivratri celebrations across tourist destinations including Jaipur, Pushkar, and Jodhpur. Enforcement focuses on charas and ganja trafficking rather than traditional bhang consumption, though the state faces cross-border challenges—15 drone-based heroin seizures from Pakistani drones occurred in 2024.
Uttar Pradesh anchors North India's bhang culture
Varanasi serves as India's bhang capital, with preparations occurring on the famous ghats and government-authorized shops throughout the city. Famous establishments include Badal Thandai (Gowdolia Chowk), considered the most renowned, and Blue Lassi (Godowlia Road), a 70-year-old institution offering 75 varieties. License fees reportedly reach ₹2 million (~$26,000) one-time payment, with monthly quotas assigned based on capacity.
Mathura, Krishna's birthplace, maintains similar traditions with the "Sarkari Bhang Theka" near the bus stop. The state legalized hemp cultivation for R&D purposes, with CSIR-NBRI obtaining a license in December 2018. Historical records show UP had India's largest cannabis consumption—287,926 pounds in 1934-35.
Punjab faces India's worst drug crisis
The state's cannabis landscape is overshadowed by a severe opioid epidemic. 75% of all drugs seized in India in 2020 were in Punjab, with 15.4% of residents reporting substance use in a 2022 survey. The crisis stems from the 553-kilometer border with Pakistan and proximity to the Golden Crescent (Afghanistan, Pakistan, Iran).
Drone smuggling has exploded: 179 cases in 2024 versus only 3 in 2021, delivering 187 kg heroin and 5 kg methamphetamine. Chitta (heroin-based drug) dominates consumption, affecting over 50% of addicts at ₹2,000/gram, while ice (methamphetamine) is emerging at ₹5,000/gram. An estimated 230,000+ opioid-dependent people include 697,000 children aged 10-17 among drug users.
Chief Minister Bhagwant Mann transferred 10,000+ police officers in February 2024 due to alleged police-drug nexus, and the Special Task Force was renamed "Anti-Narcotics Task Force" in August 2024. Cannabis consumption, including traditional bhang during festivals, continues but receives minimal policy attention compared to the opioid crisis.
Delhi combines high consumption with intensifying enforcement
The national capital consumes 38.2 tonnes of cannabis annually, ranking third globally, with a 3.8% prevalence rate among India's highest. Yet Delhi also led 2024-2025 drug trafficking cases with ₹3.07 thousand crore in seizure values. A major bust recovered 500-560 kg cocaine (largest in North India history) worth ₹5,000+ crore, with connections to South American cartels including Mexico's Cártel de Jalisco Nueva Generación.
Government-authorized bhang shops exist in Delhi-NCR, including Theka Bhang in Noida Sector 15, with availability increasing during Holi and Shivaratri. The CBD market is estimated at $150 million by 2025, with 500+ local companies producing and distributing products. Pahar Ganj near New Delhi Railway Station remains known for cannabis availability despite illegal status.
Bihar, Jharkhand, and Chhattisgarh maintain traditional practices
Bihar is among states where bhang production itself is legal, with a long tradition of consumption during festivals. Construction workers have historically used bhang to fight fatigue. Chhattisgarh shows higher cannabis prevalence alongside UP, Punjab, Sikkim, and Delhi, with significant tribal populations maintaining traditional plant medicine practices. Both states, along with Jharkhand, lack formal hemp legalization frameworks, with enforcement focused on preventing trafficking rather than traditional use.
Naxalite involvement in illegal cannabis cultivation in Central India adds a security dimension, with tribal cultivators sometimes caught between economic necessity and insurgent networks.
Southern and coastal states show diverse approaches
Gujarat's prohibition paradox
India's only complete alcohol prohibition state legalized bhang in February 2017, removing it from the "intoxicating drugs" list. Minister Pradipsinh Jadeja justified the decision as respecting "sentiments of public at large" regarding consumption as "prasad of Lord Shiva," while noting bhang is "less intoxicating as compared to ganja."
Despite prohibition, Gujarat faces significant challenges with illegal drug trade. In 2024, cannabis plantations were discovered in multiple locations including a 3-acre operation worth crores in Banaskatha's Kankrej. Hydroponic cultivation was busted in Ahmedabad residential flats with approximately 100 pots seized. Mundra Port saw ₹21,000 crore worth of drugs seized between 2021-2023. Yet a 2019 government survey recorded only 0.1% cannabis use—among the lowest nationally.
Maharashtra's enforcement remains notably relaxed
Mumbai ranks sixth globally for cannabis consumption at 32.4 tonnes annually, with enforcement described as "notably relaxed compared to other regions" and cannabis remaining "relatively accessible" in areas like Colaba. Street prices range from ₹100-700 per gram for average quality. The Bombay Prohibition Act requires licenses for bhang under Section 66(1)(b), distinguishing it from Gujarat's outright legalization.
A significant September 2024 Bombay High Court ruling clarified that ganja under NDPS covers only flowering/fruiting tops, excluding seeds, leaves, stems, and stalks—potentially affecting future prosecutions. The state expanded its Anti-Narcotics Task Force with 346 new posts in February 2025, aligning with the Union Home Minister's "zero-tolerance" declaration.
Goa tightens its historically permissive reputation
The state's historical connection to hippie trail culture and its reputation as a drug destination is confronting stricter regulation. The Goa Tourism Safety Policy 2025 requires nightclubs to cease music by 1:00 AM, bars to stop serving alcohol at 12:30 AM, and prohibits alcohol consumption within 200 meters of the waterline. GPS-tracked ride-hailing systems around nightlife hubs and educational awareness campaigns at airports signal a shift in approach.
In 2024, the Anti-Narcotic Cell seized 92.988 kg of drugs valued at ₹6.94 crore, predominantly ganja at 73.417 kg. Beach parties and casinos, described as "mainstays of tourism," also function as "channels for drug flow." Officials acknowledge Goa remains a "soft target for drug traffickers," with overdose deaths raising serious questions about enforcement effectiveness. A concerning shift from marijuana to chemical drugs has intensified risks.
Kerala maintains strict prohibition despite Ayurvedic heritage
Despite being called the "home of authentic Ayurveda" with globally recognized stature in traditional medicine, Kerala maintains strict cannabis prohibition. Bhang is not legal—the state issues no licenses, and possession can lead to penalties. The Kerala High Court dismissed a petition from someone with cannabis plants, clarifying that growing any cannabis plant is illegal regardless of flowering status.
This creates an ironic situation where Kerala's robust Ayurvedic industry cannot legally incorporate cannabis despite its prominence in classical texts including the Charaka Samhita and Sushruta Samhita. The 2019 survey recorded approximately 0.1% cannabis use—among the lowest nationally, similar to Tamil Nadu.
Tamil Nadu enforces India's strictest approach
The state maintains "Zero Cultivation" status achieved through aggressive eradication in the 1990s. Enforcement statistics are striking: 45,800 prosecutions and 68,055 arrests between 2021-2025, with over 109,000 kg cannabis seized since 2021. Conviction rates rose from 80% in 2022 to 88% by June 2025. Cannabis prevalence stands at just 0.1%—35th nationally against the 1.2% national average.
Cannabis smuggling routes flow from Andhra Pradesh, Odisha, Telangana, Manipur, Karnataka, and Goa. The state also serves as transit for Sri Lanka via sea routes. Emerging trends include ganja-infused chocolates targeting students and approximately 15% of transactions via mobile apps. Bhang sale and use are completely restricted without exceptions.
Karnataka lacks official infrastructure despite legal bhang
While the Karnataka High Court's 2022 ruling confirmed bhang from cannabis leaves is not NDPS-prohibited, no officially authorized bhang shops exist in Bangalore or elsewhere. No regulatory framework for retail sale has been established, creating a gap between legal status and practical availability.
Cannabis enforcement follows national NDPS frameworks, described as "generally ignored at user level" for small quantities but with recent crackdowns intensifying. Notably, HempCann Solutions established India's first medical cannabis clinic—Vedi Wellness Centre—in Koramangala, Bengaluru in 2020, selling legal cannabis-based oils through the Ayurvedic framework. The state's May 2025 passage of the COTPA Amendment Act raising tobacco purchase age to 21 and banning hookah bars suggests trending toward stricter substance regulation.
Odisha's Sheelavathi strain dominates India's illicit market
Odisha presents perhaps India's most complex cannabis picture. Traditional practices run deep: Trinath Puja on Mondays involves village elders and youth ceremonially smoking cannabis openly. Cannabis was historically offered as prasad at Shiva temples and mixed into sacred food, with the century-old Gharsana ritual at Akhandalamani temple involving bhang.
The 2022 government ban prohibiting cannabis at all Shiva shrines ahead of Kanwar Yatra disrupted these traditions, generating concern from temple officials about ending century-old practices. Meanwhile, a unique cannabis strain called Sheelavathi from Odisha's tribal districts now accounts for over 70% of the 23 lakh kg ganja confiscated by NCB nationwide over four years—surpassing famous varieties including Malana Cream, Idukki Gold, and Mysore Mango.
Active cultivation occurs in six mountainous districts: Koraput, Malkangiri, Rayagada, Gajapati, Boudh, and Kandhamal. Police destroyed 28,000 hectares of plantations between 2021-2023 (highest nationally), with 102.2 tonnes seized in January-July 2024 worth approximately $30 million. Drug networks pay tribals ₹10,000 per acre, providing supplies for yields of 2.5-3 quintals worth ₹50,000 investment but selling at ₹1,500-2,500/kg locally and much higher in metros.
The Northeast emerges as cultivation and consumption hub
Sikkim leads India with 7.3% cannabis use—more than double most states. Nagaland and Odisha tie at 4.7%, with Arunachal Pradesh at 4.2%. Cannabis grows wild throughout the Himalayas from Kashmir to Assam—the Latin name Cannabis indica suggesting indigenous growth.
Assam maintains India's strictest stance through the 1958 Ganja and Bhang Prohibition Act, explicitly banning both. Yet paradoxically, thousands consume during the Ambubachi Mela with police not intervening against religious consumption while fining tobacco smokers. Varieties including "Assam Hash Plant" from Barak Valley produce distinctive tropical fruit and spearmint scents.
Manipur represents future potential. Chief Minister N. Biren Singh announced in February 2020 that the state was considering legalizing cannabis cultivation for medical and industrial purposes. Ukhrul district bordering Myanmar has produced cannabis for 50+ years, dominated by the Tangkhul tribe (Naga people). "Manipuri weed" is considered among India's finest—featuring unique purple/blue streaks and strong minty taste. However, the state's position at the edge of the Golden Triangle creates complex trafficking challenges.
The medical and business landscape is rapidly evolving
Ayurvedic products find growing consumer acceptance
The legal medical cannabis market operates through traditional Ayurvedic frameworks. Trailokya Vijaya Vati—a classical formulation containing 250-500mg cannabis leaf plus Vansh Lochan (bamboo)—is the most widely available product, offered by multiple brands including Hempstreet, Hampa, CannaBlithe, and Cannazo. Full-spectrum Vijaya oils containing both CBD and THC (Indian wild-race strains are naturally THC-rich) are available in potencies from 500mg to 6500mg.
Distribution occurs through D2C websites with doctor consultation features, aggregator platforms (ItsHemp, CBD Store India), networks of trained Ayurvedic practitioners (Hempstreet claims 60,000+ doctors across 18,000+ clinics), and limited brick-and-mortar presence including BOHECO's Mumbai flagship stores. Prescription verification systems control access to Schedule E-1 products requiring medical supervision.
Major companies are attracting significant investment
BOHECO (Bombay Hemp Company), founded in 2013, has raised $9.53 million across 10 rounds, including investors like the late Ratan Tata, Peak XV Partners' Rajan Anandan, and IIMA Ventures. Revenue reached ₹7.5 crore in FY2025 (up from ₹5.3 crore), with 30-40% month-on-month growth and 45%+ repeat customer rates. The company operates farms, labs, and branded retail across wellness, nutrition, and textile verticals.
Hempstreet, founded in 2019 with $3 million in funding, claims to be India's first research-to-retail venture, maintaining CSIR partnerships and a blockchain-based "seed to sale" tracking system. International partnerships include MGC Pharma (UK) and Gynica (Israel). Awshad (2021) operates in CBD wellness and has entered pet care with Vijaya oil for animals. Cannarma received pre-seed funding at a ₹17 crore valuation in November 2023.
Research infrastructure is developing
CSIR-IIIM (Indian Institute of Integrative Medicine) in Jammu operates a major cannabis research project targeting neuropathies and cancer, signing a 2020 agreement with IndusCann (Canada). CSIR-IHBT in Palampur focuses on Himalayan bioresources including medicinal plants, working with 500+ farming families. The first-ever government license for cannabis research was issued in 2017 through a CSIR-BOHECO collaboration.
The medical cannabis market is projected to grow from $13.13 million (2023) to $26 million by 2028 at 14.64% CAGR. The Asia-Pacific CBD market is projected to reach $1.75 billion by 2029 from $173 million in 2021.
Social attitudes reveal generational and regional divides
Urban-rural and class patterns persist
Traditional acceptance runs strongest in rural areas, particularly Himalayan regions and tribal communities, where consumption remains normalized within religious and medicinal contexts. MP Tathagata Satpathy captured this normalization: "People smoking chillum is a common sight. It is not something you make note of, just as you don't notice someone drinking water or having tea."
Cannabis was historically characterized as the "intoxicant of the poor," with upper classes consuming alcohol while viewing ganja and charas as lower-class substances—though bhang during Holi crossed class boundaries. Satpathy characterized the NDPS criminalization as "elitist," reflecting class bias. Ironically, imported "Canadian hydroponic" cannabis has now become popular among "fashionable classes," inverting historical patterns.
Significant gender disparity persists: 5% of males versus only 0.6% of females report cannabis use. Patriarchal social arrangements restrict women's access and create stronger disapproval, though substance use among younger urban women is increasing.
Stigma remains substantial but is evolving
Strong social stigma persists, with cannabis associated with mental illness, criminality, and "gateway drug" narratives. Family pressure is the most common reason (70%) for seeking cannabis treatment, and internalized stigma affects users significantly.
Media portrayal has shifted dramatically. Historical Hindi cinema portrayed cannabis negatively—associated with hippie culture or criminals. Post-2000s films show urban middle-class protagonists using cannabis for relaxation, including Shaitan (2011), Go Goa Gone (2013—India's first Hindi stoner comedy), and Kapoor & Sons (2016). Director Bejoy Nambiar noted: "There's a culture of smoking up among today's youth and it's becoming more and more relevant in our movies."
College-age youth show increasing positive attitudes; 42% of Bangalore college students had seen cannabis content in films, and over one-third had searched online for cannabis products. Youth frequently argue that alcohol and tobacco remain legal despite health risks while cannabis is culturally ingrained.
Advocacy movements push for reform
The Great Legalisation Movement leads organized efforts
Founded in November 2014 in Bangalore by former journalist Viki Vaurora, GLM India has organized India's first Medical Cannabis Conference (Bengaluru, May 2015 with Rick Simpson), produced a seven-episode documentary web series, and established free cannabis health centers for cancer patients. Their December 2017 open letter to PM Narendra Modi prompted the PM's Office to direct the Ministry of Health to examine potential benefits (February 2018).
GLM's Delhi High Court petition (W.P.(C) 7608/2019), ongoing as of November 2024, seeks rules permitting and regulating medical and industrial cannabis. The petition argues the government's domestic stance contradicts its position in international forums.
Political support has emerged across party lines
Shashi Tharoor (Congress MP) wrote an influential June 2018 article titled "High Time India, Land of Bhang, Legalises Cannabis," advocating regulation for economic, health, and anti-corruption benefits. Tathagata Satpathy (former BJD MP) openly admitted cannabis use during a 2015 Reddit AMA. Maneka Gandhi (BJP Union Minister) suggested legalizing medical marijuana at a 2017 Group of Ministers meeting. Dharamvir Gandhi (former AAP, then Independent MP) introduced a Private Member's Bill in November 2016 seeking to amend the NDPS Act to allow regulated supply of "non-synthetic" intoxicants.
India's December 2020 vote at the UN Commission on Narcotic Drugs—supporting removal of cannabis from Schedule IV of the 1961 Convention (passed 27-25)—signaled potential policy shift at the international level.
Thailand's reversal offers cautionary lessons
Thailand's June 2022 decriminalization created 11,000+ dispensaries and a projected $1.2 billion industry, briefly serving as a model for Indian advocates. However, Thailand's June 2025 reversal—reclassifying cannabis as a "controlled herb" restricted to medical use after a 2024 poll showed majority support for narcotic relisting—demonstrates regulatory challenges. Indian experts note Thailand's regulatory failure as a cautionary tale for overly rapid liberalization.
Historical context explains current contradictions
Cannabis use in India predates recorded history, with the Atharvaveda (c. 1500-1000 BCE) listing bhanga among five sacred plants. Medieval Ayurvedic texts established extensive medicinal applications. Portuguese colonial observations from the 16th century documented widespread use for work, appetite, and labor relief.
The Indian Hemp Drugs Commission of 1894—appointed by the Government of India at the House of Commons' request and presided over by W. Mackworth Young—produced a 3,281-page report based on testimony from approximately 1,200 witnesses including doctors, yogis, fakirs, peasants, and hemp dealers. The Commission concluded that "moderate use of these drugs is the rule, excessive use comparatively exceptional" and that "moderate use practically produces no ill effects." It explicitly rejected total prohibition as "neither necessary nor expedient," warning it would generate religious outcry, drive consumers to dangerous substances, and create illicit markets.
India resisted American pressure to criminalize cannabis for nearly 25 years after the 1961 Single Convention on Narcotic Drugs. Indian negotiators achieved a critical victory: the treaty definition explicitly excludes leaves and seeds, preserving bhang's legality. However, under intensifying Reagan-era pressure and Cold War alliance needs, the Rajiv Gandhi government enacted the NDPS Act on November 14, 1985—which MP Satpathy later called "an overreaction to a scare created by the United States."
Conclusion: A nation at a crossroads
India's cannabis landscape reflects fundamental tensions—between ancient sacred tradition and modern prohibition, between village tolerance and urban enforcement, between Ayurvedic legitimacy and pharmaceutical regulation, between state economic development interests and central enforcement mandates. The emerging hemp industry and medical cannabis frameworks offer pathways toward regulated markets that honor cultural heritage while capturing economic value. Record enforcement seizures of ₹16,914 crore in 2024 simultaneously demonstrate both the scale of illegal trade and the limits of prohibition.
The trajectory appears to favor gradual liberalization through Ayurvedic and industrial pathways rather than recreational legalization. State-by-state experimentation—Uttarakhand's hemp cultivation, Himachal Pradesh's pilot program, Gujarat's bhang exception—creates natural experiments that will shape national policy. Thailand's regulatory reversal offers a cautionary tale against moving too quickly without adequate frameworks.
The 31 million Indians who currently consume cannabis products—through government-authorized bhang shops, underground networks, or medical Ayurvedic preparations—represent a population larger than most countries. Their practices, spanning sacred temple offerings to urban recreational use, will continue regardless of legal status. The question facing Indian policymakers is not whether cannabis culture will persist, but how to shape a regulatory environment that minimizes harms, respects traditions, captures economic value, and acknowledges a relationship with the plant stretching back thousands of years. Sacred, Banned & Booming: The Complete Story of Cannabis in India




Comments